| [1] |
Lamba N, Wen PY, Aizer AA. Epidemiology of brain metastases and leptomeningeal disease[J]. Neuro Oncol, 2021, 23(9): 1447-1456. DOI: 10.1093/neuonc/noab101.
|
| [2] |
Hatiboglu MA, Akdur K, Sawaya R. Neurosurgical management of patients with brain metastasis [J]. Neurosurg Rev, 2020, 43(2): 483-495. DOI: 10.1007/s10143-018-1013-6.
|
| [3] |
Winther RR, Hjermstad MJ, Skovlund E, et al. Surgery for brain metastases-impact of the extent of resection[J]. Acta Neurochir (Wien), 2022, 164(10): 2773-2780. DOI: 10.1007/s00701-021-05104-7.
|
| [4] |
Aizer AA, Lamba N, Ahluwalia MS, et al. Brain metastases: a Society for Neuro-Oncology (SNO) consensus review on current management and future directions[J]. Neuro Oncol, 2022, 24(10): 1613-1646. DOI: 10.1093/neuonc/noac118.
|
| [5] |
Sacks P, Rahman M. Epidemiology of brain metastases[J]. Neurosurg Clin N Am, 2020, 31(4): 481-488. DOI: 10.1016/j.nec.2020.06.001.
|
| [6] |
Rouse C, Gittleman H, Ostrom QT, et al. Years of potential life lost for brain and CNS tumors relative to other cancers in adults in the United States, 2010[J]. Neuro Oncol, 2016, 18(1): 70-77. DOI: 10.1093/neuonc/nov249.
|
| [7] |
Steindl A, Yadavalli S, Gruber K A, et al. Neurological symptom burden impacts survival prognosis in patients with newly diagnosed non-small cell lung cancer brain metastases[J]. Cancer, 2020, 126(19): 4341-4352. DOI: 10.1002/cncr.33085.
|
| [8] |
Zhu Y, Cui Y, Zheng X, et al. Small-cell lung cancer brain metastasis: from molecular mechanisms to diagnosis and treatment[J]. Biochim Biophys Acta Mol Basis Dis, 2022, 1868(12): 166557. DOI: 10.1016/j.bbadis.2022.166557.
|
| [9] |
Kim YJ, Kim JS, Kim IA. Molecular subtype predicts incidence and prognosis of brain metastasis from breast cancer in SEER database [J]. J Cancer Res Clin Oncol, 2018, 144(9): 1803-1816. DOI: 10.1007/s00432-018-2697-2.
|
| [10] |
Sun H, Xu J, Dai S, et al. Breast cancer brain metastasis: current evidence and future directions[J]. Cancer Med, 2023, 12(2): 1007-1024. DOI: 10.1002/cam4.5021.
|
| [11] |
Cagney DN, Martin AM, Catalano PJ, et al. Incidence and prognosis of patients with brain metastases at diagnosis of systemic malignancy: a population-based study[J]. Neuro Oncol, 2017, 19(11): 1511-1521. DOI: 10.1093/neuonc/nox077.
|
| [12] |
Samlowski WE, Moon J, Witter M, et al. High frequency of brain metastases after adjuvant therapy for high-risk melanoma[J]. Cancer Med, 2017, 6(11): 2576-2585. DOI: 10.1002/cam4.1223.
|
| [13] |
Niedermeyer S, Schmutzer-Sondergeld M, Weller J, et al. Neurosurgical resection of multiple brain metastases: outcomes, complications, and survival rates in a retrospective analysis[J]. J Neurooncol, 2024, 169(2): 349-358. DOI: 10.1007/s11060-024-04744-w.
|
| [14] |
Lamba N, Muskens IS, DiRisio AC, et al. Stereotactic radiosurgery versus whole-brain radiotherapy after intracranial metastasis resection: a systematic review and meta-analysis[J]. Radiat Oncol, 2017, 12(1): 106. DOI: 10.1186/s13014-017-0840-x.
|
| [15] |
Loh D, Hogg F, Edwards P, et al. Two-year experience of Multi-Disciplinary Team (MDT) outcomes for brain metastases in a tertiary neuro-oncology centre [J]. Br J Neurosurg, 2018, 32(1): 53-60. DOI: 10.1080/02688697.2017.1368449.
|
| [16] |
Cardinal T, Pangal D, Strickland BA, et al. Anatomical and topographical variations in the distribution of brain metastases based on primary cancer origin and molecular subtypes: a systematic review [J]. Neurooncol Adv, 2022, 4(1): vdab170. DOI: 10.1093/noajnl/vdab170.
|
| [17] |
Cacho-Díaz B, Lorenzana-Mendoza NA, Chávez-Hernandez JD, et al. Clinical manifestations and location of brain metastases as prognostic markers [J]. Curr Probl Cancer, 2019, 43(4): 312-323. DOI: 10.1016/j.currproblcancer.2018.06.002.
|
| [18] |
Krauss P, Kahl KH, Bonk MN, et al. Intraoperative radiotherapy after resection of brain metastases located in the posterior fossa. Analysis of postoperative morbidity and mortality in a single center cohort[J]. J Clin Neurosci, 2023, 118: 1-6. DOI: 10.1016/j.jocn.2023.09.014.
|
| [19] |
Prete AA, Angerilli V, Bergamo F, et al. HER2 expression and genOmic characterization of rESected brain metastases from colorectal cancer: the HEROES study[J]. Br J Cancer, 2024, 130(8): 1316-1323. DOI: 10.1038/s41416-023-02569-4.
|
| [20] |
Yri OE, Astrup GL, Karlsson AT, et al. Survival and quality of life after first-time diagnosis of brain metastases: a multicenter, prospective, observational study[J]. Lancet Reg Health Eur, 2025, 49: 101181. DOI: 10.1016/j.lanepe.2024.101181.
|
| [21] |
Nie Y, Ying B, Lu Z, et al. Predicting survival and prognosis of postoperative breast cancer brain metastasis: a population-based retrospective analysis[J]. Chin Med J (Engl), 2023, 136(14): 1699-1707. DOI: 10.1097/cm9.0000000000002674.
|
| [22] |
Chen TW, Dai MS, Tseng LM, et al. Whole-brain radiotherapy alone vs preceded by bevacizumab, etoposide, and cisplatin for untreated brain metastases from breast cancer: a randomized clinical trial[J]. JAMA Oncol, 2024, 10(3): 325-334. DOI: 10.1001/jamaoncol.2023.5456.
|
| [23] |
Kermanshahi N, Hamidi N, Weisberg J, et al. The prevalence of seizures in brain metastasis patients on anticonvulsant prophylaxis: a systematic review and meta-analysis[J]. World Neurosurg, 2024, 183: e613-e624. DOI: 10.1016/j.wneu.2023.12.154.
|
| [24] |
Le Rhun E, Guckenberger M, Smits M, et al. EANO-ESMO clinical practice guidelines for diagnosis, treatment and follow-up of patients with brain metastasis from solid tumours[J]. Ann Oncol, 2021, 32(11): 1332-1347. DOI: 10.1016/j.annonc.2021.07.016.
|
| [25] |
Tejada Solís S, Iglesias Lozano I, Meana Carballo L, et al. Brain metastasis treatment guidelines: consensus by the spanish society of neurosurgery tumor section[J]. Neurocirugía (English Edition), 2023, 34(6): 308-320. DOI: 10.1016/j.neucie.2023.07.010.
|
| [26] |
|
| [27] |
West TR, Mazurek MH, Perez NA, et al. Navigated intraoperative ultrasound offers effective and efficient real-time analysis of intracranial tumor resection and brain shift[J]. Oper Neurosurg, 2025, 28(2): 148-158. DOI: 10.1227/ons.0000000000001250.
|
| [28] |
Sulangi AJ, Husain A, Lei H, et al. Neuronavigation in glioma resection: current applications, challenges, and clinical outcomes[J]. Front Surg, 2024, 11: 1430567. DOI: 10.3389/fsurg.2024.1430567.
|
| [29] |
Catapano G, Sgulò FG, Acurio Padilla PE, et al. Palatal position of patient tracker for magnetic neuronavigation system: technical note[J]. World Neurosurg, 2018, 116: 105-109. DOI: 10.1016/j.wneu.2018.04.221.
|
| [30] |
Dixon L, Lim A, Grech-Sollars M, et al. Intraoperative ultrasound in brain tumor surgery: a review and implementation guide[J]. Neurosurg Rev, 2022, 45(4): 2503-2515. DOI: 10.1007/s10143-022-01778-4.
|
| [31] |
Coburger J, Scheuerle A, Pala A, et al. Histopathological insights on imaging results of intraoperative magnetic resonance imaging, 5-aminolevulinic acid, and intraoperative ultrasound in glioblastoma surgery[J]. Neurosurgery, 2017, 81(1): 165-174. DOI: 10.1093/neuros/nyw143.
|
| [32] |
Giussani C, Trezza A, Ricciuti V, et al. Intraoperative MRI versus intraoperative ultrasound in pediatric brain tumor surgery: is expensive better than cheap? A review of the literature[J]. Childs Nerv Syst, 2022, 38(8): 1445-1454. DOI: 10.1007/s00381-022-05545-0.
|
| [33] |
Giammalva GR, Ferini G, Musso S, et al. Intraoperative ultrasound: emerging technology and novel applications in brain tumor surgery[J]. Front Oncol, 2022, 12: 818446. DOI: 10.3389/fonc.2022.818446.
|
| [34] |
Wu H, Cheng Y, Gao W, et al. Progress in the application of ultrasound in glioma surgery[J]. Front Med (Lausanne), 2024, 11: 1388728. DOI: 10.3389/fmed.2024.1388728.
|
| [35] |
Ahrens LC, Krabbenhøft MG, Hansen RW, et al. Effect of 5-aminolevulinic acid and sodium fluorescein on the extent of resection in high-grade gliomas and brain metastasis[J]. Cancers (Basel), 2022, 14(3): 617. DOI: 10.3390/cancers14030617.
|
| [36] |
|
| [37] |
Musca B, Bonaudo C, Tushe A, et al. Sodium fluorescein uptake by the tumor microenvironment in human gliomas and brain metastases[J]. J Neurosurg, 2024, 140(4): 958-967. DOI: 10.3171/2023.7.JNS23873.
|
| [38] |
Schatlo B, Stockhammer F, Barrantes-Freer A, et al. 5-aminolevulinic acid fluorescence indicates perilesional brain infiltration in brain metastases[J]. World Neurosurg X, 2019, 5: 100069. DOI: 10.1016/j.wnsx.2019.100069.
|
| [39] |
Madani D, Fonseka RD, Kim SJ, et al. Comparing the rates of further resection after intraoperative MRI visualisation of residual tumour between brain tumour subtypes: a 17-year single-centre experience[J]. Brain Sci, 2025, 15(1): 45. DOI: 10.3390/brainsci15010045.
|